oasis 1 trial oral semaglutide 50 mg weight loss results Oral, Daily Cuts Pounds in Nondiabetic Patients: Efficacy and safety of oral

Youve put in the effort to transform your body, and you deserve to look as good as you feel

Mix cardiovascular exercises, strength training and flexibility routines to boost your metabolism and help you lose weight effectively

This comprehensive approach makes weight management more sustainable and achievable

Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GIP - Glucose-dependent insulinotropic polypeptide GLP-1 - Glucagon-like peptide-1 HFpEF - Heart failure with preserved ejection fraction MASH - Metabolic dysfunctionassociated steatohepatitis NASH - Nonalcoholic steatohepatitis OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Zepbound) - marketed for weight loss Tirzepatide (Mounjaro) - marketed for diabetes MECHANISM OF ACTION GLP-1 and GIP Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones secreted by intestinal cells in response to eating

It causes inflammation and oxidative stress

As noted by Kraus et al., Nature Medicine , NNMT inhibition in white adipose tissue significantly increased energy expenditure and reduced fat mass in animal models without changes to diet or activity